Does LORAZEPAM Cause Hypertransaminasaemia? 40 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Hypertransaminasaemia have been filed in association with LORAZEPAM (Lorazepam). This represents 0.1% of all adverse event reports for LORAZEPAM.
40
Reports of Hypertransaminasaemia with LORAZEPAM
0.1%
of all LORAZEPAM reports
1
Deaths
31
Hospitalizations
How Dangerous Is Hypertransaminasaemia From LORAZEPAM?
Of the 40 reports, 1 (2.5%) resulted in death, 31 (77.5%) required hospitalization, and 2 (5.0%) were considered life-threatening.
Is Hypertransaminasaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 40 reports have been filed with the FAERS database.
What Other Side Effects Does LORAZEPAM Cause?
Drug ineffective (3,775)
Drug abuse (3,741)
Toxicity to various agents (2,836)
Completed suicide (2,340)
Off label use (2,178)
Somnolence (2,114)
Sopor (2,042)
Anxiety (1,573)
Fall (1,524)
Overdose (1,516)
What Other Drugs Cause Hypertransaminasaemia?
METHOTREXATE (436)
ACETAMINOPHEN (326)
PACLITAXEL (318)
CARBOPLATIN (304)
PEMBROLIZUMAB (231)
ATORVASTATIN (207)
CYCLOPHOSPHAMIDE (202)
PREDNISONE (198)
GEMCITABINE (196)
DEXAMETHASONE (169)
Which LORAZEPAM Alternatives Have Lower Hypertransaminasaemia Risk?
LORAZEPAM vs LORCASERIN
LORAZEPAM vs LORLATINIB
LORAZEPAM vs LORMETAZEPAM
LORAZEPAM vs LORNOXICAM
LORAZEPAM vs LOSARTAN